|
Mr. Jean-Luc B�lingard, age 58, has served as a member of Tercica�s Board of Directors since October 2006. Since December 2001, Mr. B�lingard has served as Chairman and Chief Executive Officer of Ipsen. From 1999 to 2001, he was a member of the executive Board and was Chief Executive Officer of bioM�rieux-Pierre Fabre, a French healthcare conglomerate, where he was responsible for the group�s worldwide pharmaceuticals and cosmetics activities. In 1982, Mr. B�lingard joined the Roche Group, where he held several positions including head of the diagnostics division and member of the Roche Group�s corporate executive committee. Mr. B�lingard is a director of each of bioM�rieux-Pierre Fabre (France), the Laboratory Corporation of America, Applera Corporation and NicOx S.A. (France), and is also an adviser to the French government on foreign trade. Mr. B�lingard is delegate general and spokesman for G5, an association encompassing the primary French pharmaceuticals companies. He graduated from the HEC business school in 1971 and was awarded an M.B.A. from Cornell University in 1974. Mr. B�lingard was appointed to the Board of Directors of the French National Institute for Health and Medical Research in February 2006. | 